You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 605 Systemically administered HER2-targeted ISACs provoke a rapid, local response that engages the innate and adaptive arms of the immune system to eradicate tumors in preclinical models

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immune-stimulants and immune modulators
605 Systemically administered HER2-targeted ISACs provoke a rapid, local response that engages the innate and adaptive arms of the immune system to eradicate tumors in preclinical models

 

Online download statistics by month:

Online download statistics by month: November 2020 to September 2024

AbstractFullPdf
Nov 2020232031
Dec 20205609
Jan 202122010
Feb 20211607
Mar 20213405
Apr 202166011
May 20211004
Jun 2021006
Jul 2021005
Aug 20210010
Sep 2021009
Oct 202116018
Nov 202114019
Dec 20211609
Jan 20222003
Feb 20223405
Mar 20223001
Apr 20225003
May 202238015
Jun 20222006
Jul 20223002
Aug 20223005
Sep 20222008
Oct 20223403
Nov 20221604
Dec 20224203
Jan 20234604
Feb 20233605
Mar 20231606
Apr 20232403
May 20232604
Jun 20232002
Jul 20232407
Aug 20232604
Sep 20233201
Oct 20231206
Nov 20234203
Dec 20235404
Jan 20242001
Feb 20243003
Mar 20242402
Apr 20241401
May 20244605
Jun 20243801
Jul 202414013
Aug 20243801
Sep 20243002
Total14580289